Showing results (41-50 of 160) with videos related to

Sort By:
Pageof 16
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|June 18, 2011
Significance of oral administration of sodium perchlorate in planning liver-directed radioembolizationAmir Sabet, Hojjat Ahmadzadehfar, Marianne Muckle, et al.
American Journal of Nuclear Medicine and Molecular Imaging|September 22, 2025
Advancing patient education in PRRT through large language models: challenges and potentialTilman Speicher, Moritz B Bastian, Arne Blickle, et al.
Diagnostics (Basel, Switzerland)|April 26, 2024
Mind the Pitfall: Solitary Nodular Fasciitis Mimicking Extra-Nodal Manifestation of Hodgkin Lymphoma on [<sup>18</sup>F]FDG PET/CTSuginthan Markandu, Arne Blickle, Caroline Burgard, et al.
Nuklearmedizin. Nuclear Medicine|March 14, 2018
[Selective intraarterial radiotherapy (SIRT) of malignant liver tumors]Stefan P Müller, Samer Ezziddin, Gerald Antoch, et al.
EJNMMI Research|December 27, 2013
Does PRRT with standard activities of 177Lu-octreotate really achieve relevant somatostatin receptor saturation in target tumor lesions?: insights from intra-therapeutic receptor imaging in patients with metastatic gastroenteropancreatic neuroendocrine tumorsAmir Sabet, James Nagarajah, Ahmet Semih Dogan, et al.
Cancers|July 2, 2021
Renal Safety of [<sup>177</sup>Lu]Lu-PSMA-617 Radioligand Therapy in Patients with Compromised Baseline Kidney FunctionFlorian Rosar, Niklas Kochems, Mark Bartholomä, et al.
Theranostics|March 23, 2021
Molecular imaging and biochemical response assessment after a single cycle of [<sup>225</sup>Ac]Ac-PSMA-617/[<sup>177</sup>Lu]Lu-PSMA-617 tandem therapy in mCRPC patients who have progressed on [<sup>177</sup>Lu]Lu-PSMA-617 monotherapyFlorian Rosar, Fabian Hau, Mark Bartholomä, et al.
Pharmaceuticals (Basel, Switzerland)|October 23, 2021
Prophylactic Peripheral Blood Stem Cell Collection in Patients with Extensive Bone-Marrow Infiltration of Neuroendocrine Tumours Prior to Peptide Receptor Radionuclide Therapy with <sup>177</sup>Lu-DOTATATEAmir Sabet, Nicolai Mader, Jörg Thomas Bittenbring, et al.
Cancers|June 10, 2022
Addition of Standard Enzalutamide Medication Shows Synergistic Effects on Response to [<sup>177</sup>Lu]Lu-PSMA-617 Radioligand Therapy in mCRPC Patients with Imminent Treatment Failure-Preliminary Evidence of Pilot ExperienceFlorian Rosar, Hanna Bader, Mark Bartholomä, et al.
Parkinsonism & Related Disorders|October 23, 2016
Reduced MIBG accumulation of the parotid and submandibular glands in idiopathic Parkinson's diseaseJaweed Haqparwar, Antonio Pepe, Klaus Fassbender, et al.
Pageof 16